Private equity firms are holding 33,575 portfolio companies they cannot exit at investor-required valuations, even as M&A volumes recover and IPO windows reopen selectively. The inventory represents a structural overhang distinct from deal flow—firms are transacting, but not clearing positions purchased at 2020-2021 marks.
The accumulation stems from vintage mismatch. Funds raised between 2019 and 2021 deployed capital at 14-18x EBITDA multiples in software, healthcare services, and consumer brands. Current exit multiples in those sectors trade 20-35% below entry marks, creating a hard floor on realizations. Firms cannot distribute without crystallizing losses that breach return hurdles, so they hold. Portfolio duration has extended from 4.2 years in 2019 to 6.1 years in 2025, per Preqin data. The unsold inventory is growing faster than new acquisitions close.
This matters because LP capital is frozen in place. University endowments, pension systems, and family offices have $2.8 trillion committed to private equity strategies, with $1.1 trillion sitting in funds past their anticipated hold periods. Denominator effects worsen—public equity gains in 2024-2025 pushed PE allocations above target bands at 140 institutions tracked by Cambridge Associates, but those LPs cannot rebalance because distributions have stalled. The result is capital calls declining 22% year-over-year while funds sit on dry powder they cannot deploy without violating concentration limits. Secondary markets are pricing these trapped positions at 72-81 cents on NAV, depending on vintage and sector exposure.
The overhang intersects with private credit strain documented in separate filings. Direct lenders underwrote $340 billion in LBO financings since 2021, much of it supporting the same vintage portfolios now unable to exit. Default rates in private credit broke 4.2% in Q2 2025, up from 1.8% a year prior. Software companies with $25-150 million EBITDA—the core middle-market LBO target—are seeing covenant breaches rise as growth rates normalize and interest coverage thins. PE sponsors are choosing to inject equity or negotiate amend-and-extends rather than trigger sales at distressed marks. The result is capital recycling into the same stuck positions instead of returning to LPs.
Operators should monitor three developments through Q4 2025 and into 2026. First, continuation fund activity—sponsors buying their own portfolios from existing funds to reset the clock without exiting. Volume hit $28 billion in H1 2025, up 40% year-over-year, but represents musical chairs rather than liquidity. Second, dividend recaps funded by private credit—extracting cash without selling, which adds leverage to already-stretched portfolios. Third, the 2026 fundraising cycle, where GPs will need to show distributions to close new vehicles. Funds with 2019-2020 vintages face LP pressure in 6-9 months.
The 33,575 figure is not inventory waiting for better markets. It is capitalStructurally repriced, held because the alternative is admitting the entry price was wrong.